Nolato AB (publ) (NOLA-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nolato AB (publ) (NOLA-B) has a cash flow conversion efficiency ratio of -0.080x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-442.00 Million ≈ $-47.57 Million USD) by net assets (Skr5.53 Billion ≈ $595.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nolato AB (publ) - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Nolato AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NOLA-B liabilities breakdown for a breakdown of total debt and financial obligations.
Nolato AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nolato AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guilin Fuda Co Ltd
SHG:603166
|
0.019x |
|
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
|
0.051x |
|
Fujian Aonong Biological Technology Group Incorporation Ltd
SHG:603363
|
0.008x |
|
Ardent Health Partners, Inc.
NYSE:ARDT
|
0.132x |
|
Shaanxi Provincial Natural Gas Co Ltd
SHE:002267
|
0.032x |
|
Savers Value Village, Inc.
NYSE:SVV
|
0.208x |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
|
0.006x |
|
Forestar Group Inc
NYSE:FOR
|
-0.088x |
Annual Cash Flow Conversion Efficiency for Nolato AB (publ) (2004–2025)
The table below shows the annual cash flow conversion efficiency of Nolato AB (publ) from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Nolato AB (publ) stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr5.53 Billion ≈ $595.33 Million |
Skr310.00 Million ≈ $33.36 Million |
0.056x | -76.65% |
| 2024-12-31 | Skr5.74 Billion ≈ $617.50 Million |
Skr1.38 Billion ≈ $148.19 Million |
0.240x | +58.89% |
| 2023-12-31 | Skr5.17 Billion ≈ $556.48 Million |
Skr781.00 Million ≈ $84.05 Million |
0.151x | +100.59% |
| 2022-12-31 | Skr5.39 Billion ≈ $580.27 Million |
Skr406.00 Million ≈ $43.69 Million |
0.075x | -70.76% |
| 2021-12-31 | Skr4.77 Billion ≈ $513.11 Million |
Skr1.23 Billion ≈ $132.15 Million |
0.258x | -18.15% |
| 2020-12-31 | Skr3.70 Billion ≈ $398.07 Million |
Skr1.16 Billion ≈ $125.26 Million |
0.315x | -19.54% |
| 2019-12-31 | Skr2.97 Billion ≈ $319.19 Million |
Skr1.16 Billion ≈ $124.83 Million |
0.391x | -2.99% |
| 2018-12-31 | Skr2.59 Billion ≈ $278.94 Million |
Skr1.04 Billion ≈ $112.46 Million |
0.403x | +12.60% |
| 2017-12-31 | Skr2.16 Billion ≈ $232.34 Million |
Skr773.00 Million ≈ $83.19 Million |
0.358x | +42.14% |
| 2016-12-31 | Skr1.85 Billion ≈ $199.09 Million |
Skr466.00 Million ≈ $50.15 Million |
0.252x | -16.71% |
| 2015-12-31 | Skr1.76 Billion ≈ $189.30 Million |
Skr532.00 Million ≈ $57.25 Million |
0.302x | +43.62% |
| 2014-12-31 | Skr1.57 Billion ≈ $168.63 Million |
Skr330.00 Million ≈ $35.51 Million |
0.211x | -44.55% |
| 2013-12-31 | Skr1.35 Billion ≈ $145.07 Million |
Skr512.00 Million ≈ $55.10 Million |
0.380x | -3.85% |
| 2012-12-31 | Skr1.21 Billion ≈ $129.68 Million |
Skr476.00 Million ≈ $51.23 Million |
0.395x | +84.82% |
| 2011-12-31 | Skr1.15 Billion ≈ $123.87 Million |
Skr246.00 Million ≈ $26.47 Million |
0.214x | -31.90% |
| 2010-12-31 | Skr1.18 Billion ≈ $126.88 Million |
Skr370.00 Million ≈ $39.82 Million |
0.314x | +32.61% |
| 2009-12-31 | Skr1.09 Billion ≈ $116.87 Million |
Skr257.00 Million ≈ $27.66 Million |
0.237x | -44.48% |
| 2008-12-31 | Skr1.06 Billion ≈ $113.86 Million |
Skr451.00 Million ≈ $48.53 Million |
0.426x | +20.37% |
| 2007-12-31 | Skr881.00 Million ≈ $94.81 Million |
Skr312.00 Million ≈ $33.58 Million |
0.354x | +0.87% |
| 2006-12-31 | Skr789.00 Million ≈ $84.91 Million |
Skr277.00 Million ≈ $29.81 Million |
0.351x | -4.85% |
| 2005-12-31 | Skr832.00 Million ≈ $89.54 Million |
Skr307.00 Million ≈ $33.04 Million |
0.369x | -32.11% |
| 2004-12-31 | Skr655.00 Million ≈ $70.49 Million |
Skr356.00 Million ≈ $38.31 Million |
0.544x | -- |
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more